Essex In the News

DUBLIN and LANGHORNE, Pennsylvania—Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and EUSA Pharma Inc. today announced that the companies have signed a definitive agreement under which Jazz Pharmaceuticals has agreed to acquire EUSA Pharma, a privately-held, specialty pharmaceutical company with headquarters in the United States and United Kingdom, for $650 million in…  

DANVERS, Massachusetts—Abiomed, a provider of heart support technologies, reported that it has received CE mark approval to market the Impella cVAD device, a new percutaneous Impella heart pump that provides peak flow of about 4 liters of blood per minute.  The Impella cVAD is designed to provide temporary circulatory support…  

CHICAGO, IL — Horizon Pharma Inc. has secured more than $80 million in new funding as the Deerfield-based firm ramps up marketing of its first drug, a pain reliever, and gets ready to roll out another product later this year.

The startup, which is backed by Palo Alto, Calif.-based Essex…  

ZURICH-SCHLIEREN, Switzerland—Molecular Partners AG today commented on the recent progress with its anti-VEGF DARPin (AGN-150998/MP0112), which is being developed in partnership with Allergan for ocular indications. Allergan announced last week at their R&D day that the compound
successfully completed phase IIa development. AGN-150998/MP0112 was shown to be safe and…  

MOUNTAIN VIEW, California — In Silicon Valley, the line between computing and biology has begun to blur in a way that could have enormous consequences for human longevity. 

Bill Banyai, an optical physicist at Complete Genomics, has helped make that happen. When he began developing a gene sequencing machine,…